BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

Leases (Tables)

3 Months Ended

Mar. 31, 2023

Information related to the Company’s right-of-use assets and related liabilities were as follows (in thousands):


	Three Months Ended
	March 31,
	2023			2022
Cash paid for operating lease liabilities	$	68		$	66
Right-of-use assets obtained in exchange for new operating lease obligations	$	464		$	444
Weighted-average remaining lease term	2.5 years			3.4 years
Weighted-average discount rate		12.3	%		12.3	%

Schedule of Maturities of Lease Liabilities

Maturities of lease liabilities as of March 31, 2023 for leases that have commenced are as follows (in thousands):


	March 31,
2024	$	994
2025		984
2026		608
2027		—
2028 and thereafter		—
Total future minimum lease obligations		2,586
Less imputed interest		(383	)
Total lease liabilities	$	2,203

Current operating lease liabilities, included in accrued liabilities	$	771
Non current lease liabilities		1,432
Total lease liabilities	$	2,203

Future minimum rental commitments under lease agreements with non-cancelable Operating Leases

Future minimum rental commitments under lease agreements, as of March 31, 2023, with non-cancelable terms greater than one year for each of the years ending December 31 are as follows (in thousands):


	Year Ended
	December 31,
Remainder of 2023	$	734
2024		1,042
2025		810
2026		—
2027 and thereafter		—
Total future minimum lease obligations		2,586
Less imputed interest		(383	)
Total lease liabilities	$	2,203